- Home
- MCY vs RNA Comparison
MCY vs RNA Comparison
Compare MCY & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCY
- RNA
- Stock Information
- Founded
- MCY 1961
- RNA 2012
- Country
- MCY United States
- RNA United States
- Employees
- MCY N/A
- RNA N/A
- Industry
- MCY Property-Casualty Insurers
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- MCY Finance
- RNA Health Care
- Exchange
- MCY Nasdaq
- RNA Nasdaq
- Market Cap
- MCY 3.7B
- RNA 3.7B
- IPO Year
- MCY N/A
- RNA 2020
- Fundamental
- Price
- MCY $52.25
- RNA $31.12
- Analyst Decision
- MCY Strong Buy
- RNA Strong Buy
- Analyst Count
- MCY 1
- RNA 10
- Target Price
- MCY $80.00
- RNA $65.80
- AVG Volume (30 Days)
- MCY 951.7K
- RNA 1.3M
- Earning Date
- MCY 02-11-2025
- RNA 03-07-2025
- Dividend Yield
- MCY 2.43%
- RNA N/A
- EPS Growth
- MCY 385.68
- RNA N/A
- EPS
- MCY 8.45
- RNA N/A
- Revenue
- MCY $5,475,633,000.00
- RNA $10,117,000.00
- Revenue This Year
- MCY N/A
- RNA N/A
- Revenue Next Year
- MCY $7.13
- RNA N/A
- P/E Ratio
- MCY $6.19
- RNA N/A
- Revenue Growth
- MCY 18.27
- RNA N/A
- 52 Week Low
- MCY $44.19
- RNA $13.73
- 52 Week High
- MCY $80.72
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- MCY 46.18
- RNA 44.06
- Support Level
- MCY $50.27
- RNA $31.14
- Resistance Level
- MCY $62.84
- RNA $33.37
- Average True Range (ATR)
- MCY 2.69
- RNA 1.67
- MACD
- MCY 0.74
- RNA -0.16
- Stochastic Oscillator
- MCY 28.01
- RNA 11.27
About MCY Mercury General Corporation
Mercury General Corp is an insurance holding company. It is engaged in writing personal automobile insurance and provides related property and casualty insurance products. The Company offers the following types of automobile coverage: collision, property damage, bodily injury ("BI"), comprehensive, personal injury protection ("PIP"), underinsured and uninsured motorist, and other hazards. The Company offers the following types of homeowners coverage: dwelling, liability, personal property, and other coverages.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.